KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Amortization of Deferred Charges (2016 - 2025)

Bausch Health Companies' Amortization of Deferred Charges history spans 17 years, with the latest figure at $22.0 million for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 57.14% year-over-year to $22.0 million; the TTM value through Dec 2025 reached $94.0 million, up 70.91%, while the annual FY2025 figure was $94.0 million, 70.91% up from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $22.0 million at Bausch Health Companies, up from $16.0 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $50.0 million in Q2 2022 and bottomed at $11.0 million in Q1 2023.
  • The 5-year median for Amortization of Deferred Charges is $14.0 million (2022), against an average of $18.4 million.
  • The largest annual shift saw Amortization of Deferred Charges skyrocketed 316.67% in 2022 before it plummeted 76.0% in 2023.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $13.0 million in 2021, then changed by 0.0% to $13.0 million in 2022, then increased by 7.69% to $14.0 million in 2023, then changed by 0.0% to $14.0 million in 2024, then soared by 57.14% to $22.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Amortization of Deferred Charges are $22.0 million (Q4 2025), $16.0 million (Q3 2025), and $41.0 million (Q2 2025).